Skip to main content

Advertisement

ADVERTISEMENT

Hidradenitis Suppurativa Q&As

Dr Amit Garg: Comorbidity Screening in HS
Q&As
05/19/2021
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights...
05/19/2021
The Dermatologist
Dr Haley Naik on Hidradenitis Suppurativa: Current Medical and Surgical Management
Q&As
04/24/2021
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD...
04/24/2021
The Dermatologist
The Who and When of Intralesional Injections for HS Treatment
Q&As
03/26/2021
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met...
03/26/2021
The Dermatologist

Advertisement

Advertisement